These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27930300)

  • 1. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma.
    Gujar AD; Le S; Mao DD; Dadey DY; Turski A; Sasaki Y; Aum D; Luo J; Dahiya S; Yuan L; Rich KM; Milbrandt J; Hallahan DE; Yano H; Tran DD; Kim AH
    Proc Natl Acad Sci U S A; 2016 Dec; 113(51):E8247-E8256. PubMed ID: 27930300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
    Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel resistance mechanisms to NAMPT inhibition via the de novo NAD
    Guo J; Lam LT; Longenecker KL; Bui MH; Idler KB; Glaser KB; Wilsbacher JL; Tse C; Pappano WN; Huang TH
    Biochem Biophys Res Commun; 2017 Sep; 491(3):681-686. PubMed ID: 28756225
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
    Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
    Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK
    Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.
    Tateishi K; Iafrate AJ; Ho Q; Curry WT; Batchelor TT; Flaherty KT; Onozato ML; Lelic N; Sundaram S; Cahill DP; Chi AS; Wakimoto H
    Clin Cancer Res; 2016 Sep; 22(17):4452-65. PubMed ID: 27076630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regenerative Neurogenesis After Ischemic Stroke Promoted by Nicotinamide Phosphoribosyltransferase-Nicotinamide Adenine Dinucleotide Cascade.
    Zhao Y; Guan YF; Zhou XM; Li GQ; Li ZY; Zhou CC; Wang P; Miao CY
    Stroke; 2015 Jul; 46(7):1966-74. PubMed ID: 26060246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
    Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
    Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferation effect of APO866 on C6 glioblastoma cells by inhibiting nicotinamide phosphoribosyltransferase.
    Zhang LY; Liu LY; Qie LL; Ling KN; Xu LH; Wang F; Fang SH; Lu YB; Hu H; Wei EQ; Zhang WP
    Eur J Pharmacol; 2012 Jan; 674(2-3):163-70. PubMed ID: 22119381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local Targeting of NAD
    Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
    Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma.
    Peterse EFP; van den Akker BEWM; Niessen B; Oosting J; Suijker J; de Jong Y; Danen EHJ; Cleton-Jansen AM; Bovée JVMG
    Mol Cancer Res; 2017 Dec; 15(12):1714-1721. PubMed ID: 28860121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.
    Soncini D; Caffa I; Zoppoli G; Cea M; Cagnetta A; Passalacqua M; Mastracci L; Boero S; Montecucco F; Sociali G; Lasigliè D; Damonte P; Grozio A; Mannino E; Poggi A; D'Agostino VG; Monacelli F; Provenzani A; Odetti P; Ballestrero A; Bruzzone S; Nencioni A
    J Biol Chem; 2014 Dec; 289(49):34189-204. PubMed ID: 25331943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway.
    Feng J; Yan PF; Zhao HY; Zhang FC; Zhao WH; Feng M
    Biomed Res Int; 2016; 2016():1450843. PubMed ID: 28097126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different Effects of RNAi-Mediated Downregulation or Chemical Inhibition of NAMPT in an Isogenic IDH Mutant and Wild-Type Glioma Cell Model.
    Clausing M; William D; Preussler M; Biedermann J; Grützmann K; Richter S; Buchholz F; Temme A; Schröck E; Klink B
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal regulation by hypoxia-inducible factor-2α and the NAMPT-NAD(+)-SIRT axis in articular chondrocytes is involved in osteoarthritis.
    Oh H; Kwak JS; Yang S; Gong MK; Kim JH; Rhee J; Kim SK; Kim HE; Ryu JH; Chun JS
    Osteoarthritis Cartilage; 2015 Dec; 23(12):2288-2296. PubMed ID: 26209889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nampt expression increases during osteogenic differentiation of multi- and omnipotent progenitors.
    Li Y; He J; He X; Li Y; Lindgren U
    Biochem Biophys Res Commun; 2013 Apr; 434(1):117-23. PubMed ID: 23537654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC inhibitor sodium butyrate augments the MEF2C enhancement of Nampt expression under hypoxia.
    Yan SF; You HJ; Xing TY; Zhang CG; Ding W
    Curr Pharm Des; 2014; 20(11):1604-13. PubMed ID: 23888946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
    Hesari Z; Nourbakhsh M; Hosseinkhani S; Abdolvahabi Z; Alipour M; Tavakoli-Yaraki M; Ghorbanhosseini SS; Yousefi Z; Jafarzadeh M; Yarahmadi S
    Gene; 2018 Oct; 673():149-158. PubMed ID: 29886033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide phosphoribosyltransferase/sirtuin 1 pathway is involved in human immunodeficiency virus type 1 Tat-mediated long terminal repeat transactivation.
    Zhang HS; Sang WW; Wang YO; Liu W
    J Cell Biochem; 2010 Aug; 110(6):1464-70. PubMed ID: 20506278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.
    Svoboda P; Krizova E; Sestakova S; Vapenkova K; Knejzlik Z; Rimpelova S; Rayova D; Volfova N; Krizova I; Rumlova M; Sykora D; Kizek R; Haluzik M; Zidek V; Zidkova J; Skop V
    J Biol Chem; 2019 May; 294(22):8676-8689. PubMed ID: 30975903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.